Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001133884-03-000492
Filing Date
2003-07-15
Accepted
2003-07-15 16:57:04
Documents
6
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 10-K g10k-31374.txt 10-K 294255
3 EX-21 gex21_31374.txt EX-21 213
4 EX-23.1.1 gex2311-31374.txt EX-23.1.1 664
5 EX-23.1.2 gex2312-31374.txt EX-23.1.2 750
6 EX-99.1 gex99_1-31374.txt EX-99.1 1489
7 EX-99.2 gex99_2-31374.txt EX-99.2 1516
  Complete submission text file 0001133884-03-000492.txt   300916
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 03787691
SIC: 2834 Pharmaceutical Preparations